REMSIMA

This brand name is authorized in Australia, Austria, Brazil, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Germany, Hong Kong SAR China, Ireland, Israel, Italy, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug REMSIMA contains one active pharmaceutical ingredient (API):

1	Infliximab UNII B72HH48FLU - INFLIXIMAB
	Infliximab is a chimeric human-murine monoclonal antibody that binds with high affinity to both soluble and transmembrane forms of TNFα but not to lymphotoxin α (TNFβ).
	Read more about Infliximab

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L04AB02	Infliximab	L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AB Tumor necrosis factor alpha (TNF-α) inhibitors
Discover more medicines within L04AB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	12550M, 12551N, 12552P, 12553Q, 12554R, 12555T, 12560C, 12561D, 12566J, 12567K, 12575W, 12576X, 12577Y, 12584H, 12585J, 12586K, 12587L, 12597B
BR	Câmara de Regulação do Mercado de Medicamentos	545116050000007
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	05040085, 10826310, 10826327, 10826333, 10826356, 10826385, 10917159, 11027976, 11027982, 11027999, 11028007, 11028013, 11126879, 11133690, 11133709, 11133715, 11133721, 11133738, 11144268, 11144280, 11144297, 11144334, 11144363, 11155125, 11155941, 11155958, 11155964, 11155970, 11155987, 11174186, 11174200, 11174223, 11174252, 11174269, 11224257, 11228663, 11512944, 11512973, 11512996, 11513004, 11532289, 11532332, 11532349, 11606510, 11697228, 11697234, 11697240, 11697257, 13169829, 13704116, 14055246, 15253474, 15433874, 15433880, 15433897, 15433905, 15617232, 15617249, 15617261, 15617278, 15617284, 15658113, 15658136, 15896485, 15896491, 16743772, 16743789, 16743795, 16799005, 16799034, 16799040, 16799057, 16799063, 17274641, 17302828
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	HG340813
EE	Ravimiamet	1624867, 1674211, 1674222, 1674233, 1674244, 1785001, 1806803, 1806814, 1806836, 1806847, 1806858, 1806869, 1824353, 1824364
ES	Centro de información online de medicamentos de la AEMPS	1130853006, 1130853012, 13853001, 13853001IP1
FI	Lääkealan turvallisuus- ja kehittämiskeskus	069790, 155173, 395226, 441933, 525708, 543722, 559619
FR	Base de données publique des médicaments	64428871, 67582262, 68279040
GB	Medicines & Healthcare Products Regulatory Agency	288038, 380046, 380049
HK	Department of Health Drug Office	65013, 65014
IL	מִשְׂרַד הַבְּרִיאוּת	7887, 8807
IT	Agenzia del Farmaco	042942019, 042942021, 042942033, 042942045, 042942058, 042942060, 042942072, 042942084, 042942096, 042942108, 042942110, 042942122, 042942134, 042942146, 042942159, 042942161, 042942173
LT	Valstybinė vaistų kontrolės tarnyba	1071197, 1076143, 1076144, 1076145, 1076146, 1086747, 1089028, 1089029, 1089030, 1089031, 1089032, 1089033, 1089034, 1089035, 1089036, 1090326, 1090327, 1090328
NL	Z-Index G-Standaard, PRK	201707, 201715, 54542
NZ	Medicines and Medical Devices Safety Authority	16218
PL	Rejestru Produktów Leczniczych	100303921, 100463270, 100463288
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W60071001, W66531001, W66531002, W66531003, W66531004, W66531005, W66531006, W66531007, W66531008, W66531009, W66531010, W66531011, W66531012
SG	Health Sciences Authority	14972P
TN	Direction de la Pharmacie et du Médicament	6653671H
TR	İlaç ve Tıbbi Cihaz Kurumu	8680614140112